BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$18.56
1.80 (10.74%)
▲
5d:
+11.94%
30d:
-9.73%
90d:
-38.69%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Jun 05, 2026
20d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $18.56, which is considered fair relative to its 30-day fair value range of $16.12 to $20.13.
Technical Outlook: Technically, BNR is in a downtrend. The price is approaching resistance at $18.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNR is in a downtrend. The price is approaching resistance at $18.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$16.12 -
$20.13
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.7%)
- BEARISH: Trading 78.3% above Wall St target ($4.03)
Trading Range Analysis
30-Day Trading Range
$16.12 -
$20.13
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$15.83
Resistance Level
$18.59
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Wall Street Target
$4.03
(-78.3%)
Revenue Growth (YoY)
0.2%
Profit Margin
-10.3%
Share & Embed Analysis
Last updated: May 15, 2026 9:03 AM ET
Data refreshes hourly during market hours. Next update: 10:03 AM
Data refreshes hourly during market hours. Next update: 10:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 58 HOLD |
